Clinical Trials Logo

Clinical Trial Summary

Objectives:

a) Principal: To assess if the fibrin glue or the tranexamic acid reduce less than 20% the blood losses with respect to the habitual haemostasia in patients with arthroplasty total of knee.

Secondaries: To assess the treatment safety. To perform a cost- analyses.

Methods: Randomized, unicentric, and parallel clinical trial with four comparative groups: Tissucol® (fibrin glue), fibrin glue manufactured by the Cryoseal® system (Banc de Sang i Teixits de Catalunya), tranexamic acid and habitual haemostasia.

Nº of participant centres: 1. Random allocation will be centralised.

Main outcome: Blood losses (ml) in the post-operatory period collected by the habitual drain system.

Secondary outcomes: Proportion of patients with blood transfusion, complications of surgery wound, pre and post-operative haemoglobin, units of blood transfused, post-operative mortality, days of hospital stay, safety of interventions assessed.

Size sample calculation: The number needed of patients is 172 (43 per group) to demonstrate a 20% difference in the post-operative blood losses between the treatments assessed and the habitual haemostasia, with a statistical power of 80% and a 0.05 bilateral alpha, and a 20% of withdrawals.

Statistical analysis: The investigators will perform a comparison of outcomes through the "t" test, the Mann-Whitney test of chi square, depending of the evaluated outcomes, quantitative or ordinals or qualitative, respectively. The software used will be Statistical Package for the Social Sciences (SPSS) version 17.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01306370
Study type Interventional
Source Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact
Status Completed
Phase Phase 3
Start date June 2010
Completion date November 2011

See also
  Status Clinical Trial Phase
Recruiting NCT04058743 - Nickel Sensitivity N/A
Completed NCT06321952 - Comparison of Accuracy and Functional Outcome Between Robotic and Gyroscopic Assisted Surgery in Primary TKA N/A
Recruiting NCT06005623 - Motivational Feedback Following Total or Unicompartmental Knee Arthroplasty N/A
Completed NCT06159205 - Core Stability Via Telerehabitation on TKA N/A
Terminated NCT03665233 - Virtual Reality for Post Operative Pain Management After Total Knee Arthroplasty N/A
Recruiting NCT04229368 - Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications N/A
Withdrawn NCT03840122 - ACB + IPACK Block With or Without Local Infiltration in RA-TKA N/A
Recruiting NCT05583630 - Ligament Tension Measurement in Knee Arthroplasty
Recruiting NCT06120023 - Post-Market Clinical Follow Up for Total Knee Arthroplasty System Madison
Completed NCT05875324 - Effects of Virtual Reality in TKA Patients N/A
Completed NCT03230942 - Effect of Pre-op Patient Education on Functional Outcomes After TKA N/A
Completed NCT03302832 - Effectiveness of Reduced Frequency Physical Therapy in Total Knee Arthroplasty N/A
Completed NCT03454256 - Virtual Reality Rehabilitation in Patients With Total Knee Replacement N/A
Completed NCT05802368 - Hemophilic Knee Arthropathy Virtual Reality N/A
Completed NCT05478005 - Function and Pain Following Knee Replacement N/A
Recruiting NCT03495232 - Persona Cohort Nordic Multicenter Study
Completed NCT04183673 - Laser + Cryo-thermal Therapy Following Total Knee Replacement Surgery N/A
Not yet recruiting NCT06337123 - Physica TT Tibial Plate Follow up Study
Completed NCT04883788 - The Impact of COVID-19 Pandemic on Hip and Knee Replacement
Active, not recruiting NCT04598568 - Post-market Clinical Follow-up on the balanSys UNI Knee Prosthesis Implanted With a Spacer Block Surgical Technique